Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open multicentre phase 4 study of Dysport 500 Units in heterogeneous cervical dystonia
2004-002086-20Phase 4Completed
- Sponsor
- Ipsen
- Start
- Feb 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of botulinum toxin type A in cervical dystonia (CD), sponsored by Ipsen. Primary endpoint: Primary efficacy endpoint. Started Feb 2005; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on 2004-002086-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002086-20.